Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines
about
Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment.Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.
P2860
Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@ast
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@en
type
label
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@ast
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@en
prefLabel
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@ast
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@en
P2093
P2860
P356
P1476
Preclinical evaluation of Vaxf ...... whole virus influenza vaccines
@en
P2093
Alain Rolland
Astrid Kerschbaum
Brian A Crowe
Helga Savidis-Dacho
Larry R Smith
Mark Shlapobersky
Michael G Schwendinger
Otfried Kistner
P Noel Barrett
Peter Bruehl
P2860
P304
P356
10.4161/HV.24209
P577
2013-03-06T00:00:00Z